Mr. Di-Cori’s vast healthcare experience includes President of LifeWatch Technologies, a developer of technologies that help physicians detect symptoms.
IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually.
Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equityThrough early,.